Volume 21, Number 7—July 2015
CME ACTIVITY - Research
Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013–2014
Table 1
Results of PCR testing of specimens from patients from New South Wales received at the VIDRL, Melbourne, Victoria, Australia, November 1, 2013–February 28, 2014 *
Test | Specimens, no. (%) | Patients, no. (%) |
---|---|---|
Total no. | 420 (100) | 308 (100) |
PCR+ for HPeV | 289 (69) | 198 (64) |
PCR+ for HPeV only | 285 (68) | 194 (63) |
PCR+ for HPeV and EV† | 4 (1) | 4 (1) |
PCR+ for EV only | 15 (4) | 14 (5) |
PCR+ for EV | 19 (5) | 18 (6) |
PCR− for HPeV | 131 (31) | 110 (36) |
PCR− for HPeV and EV | 116 (28) | 96 (31) |
*EV, enterovirus; HPeV, human parechovirus;VIDRL, Victorian Infectious Disease Reference Laboratory: +, positive; –, negative.
†Because of how the testing algorithm is set up at VIDRL, all samples tested for HPeV are also tested for EV. EV results are shown to demonstrate the small amount of EV detected in this HPeV outbreak period, with even fewer co-infections.
1Current affiliation: Independent consultant, Freshwater, New South Wales, Australia